RespireRx Pharmaceuticals Inc (RSPI)

[drfreely]

Will need to test .17 support levels and have trading volumes that exceed a million shares or so before we draw any conclusions about technicals. Since many on this board need well over a dollar to approach breaking even, they might not share our excitement, particularly in light of the oft-stated complaint that management perpetually fails to deliver, never owns up to mistakes, and in essence exists only to perpetuate their salaries since no other pharma would consider them viable job candidates unless they were willing to accept employment euthanizing lab rats at the end point of an animal trial conducted by a biotech company capable of funding, monitoring, and completing an FDA approved acute tox trial. This is not my opinion, but one that I suspect may be held by many trapped longs.